Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
ICAA, HO-1, and HBV Replication: Mechanistic Insights
2026-09-04
The reference study shows that isochlorogenic acid A (ICAA) suppresses hepatitis B virus replication at multiple stages, including transcription, cccDNA maintenance, capsid formation, and envelopment. Its findings connect HO-1-associated reactive oxygen species modulation with altered viral structural-protein chemistry, providing a mechanistic framework for studying host-directed antiviral effects.
-
Naloxone Hydrochloride: A Mechanism-First Guide
2026-09-03
Naloxone hydrochloride is more than a standard opioid receptor antagonist: it is a powerful tool for separating receptor-mediated signaling from receptor-independent cellular effects. This mechanism-first guide connects opioid, neural, and immune assays with practical lessons from modern inhibitor-discovery research.
-
N4-Acetylcytidine: From Structure to Translation
2026-09-02
N4-Acetylcytidine is more than a modified nucleoside standard. Recent structural work separates free ac4C metabolism from RNA-embedded modification biology, providing a sharper framework for enzyme assays, RNA structure-function analysis, reagent selection, and translational interpretation.
-
ICG001 for Reliable Wnt Assays
2026-09-02
Learn how ICG001 (SKU A8217) can improve interpretation of cell viability, proliferation, and cytotoxicity experiments involving Wnt/β-catenin signaling. This scenario-based guide covers mechanism, assay design, dosing, controls, compound handling, and vendor-selection criteria.
-
TG003 and the Translational Logic of CLK2 Biology
2026-09-01
TG003 offers a reversible pharmacological route to interrogate Cdc2-like kinase biology, alternative splicing, and the CLK2–BRCA1 axis implicated in platinum resistance. This thought-leadership analysis connects splice-factor phosphorylation with translational study design while distinguishing validated evidence from forward-looking hypotheses.
-
Quizartinib (AC220) Workflow for FLT3 Studies
2026-09-01
Build reproducible FLT3 pathway experiments with Quizartinib (AC220), from phospho-protein assays and AML cell viability studies to resistance-aware xenograft workflows. A cross-domain section uses recent norovirus–NINJ1 findings to sharpen assay controls without implying that Quizartinib directly regulates viral secretion.
-
AA–HMF Co-exposure and Ferroptotic Gut Injury
2026-08-31
A 2026 Food Bioscience study shows that simultaneous exposure to acrylamide and 5-hydroxymethylfurfural damages IEC-6 intestinal epithelial cells through redox imbalance, mitochondrial dysfunction, and ferroptosis-associated signaling. Its combination of pharmacological rescue, molecular profiling, and transcriptomics provides a useful framework for distinguishing ferroptotic injury from general oxidative cytotoxicity.
-
dhcr7 Knockout Grass Carp Shows GCRV Resistance
2026-08-31
A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and found approximately 40% higher survival after GCRV-II challenge. The work links cholesterol biosynthesis with antiviral immunity in vivo, identifying dhcr7 as a disease-resistance breeding target without detectable penalties for growth or muscle morphology.
-
A Broad-Spectrum mRNA Vaccine for Omicron and SARS-CoV
2026-08-30
Guan and colleagues engineered a lipid nanoparticle-encapsulated mRNA vaccine that replaces the mutable SARS-CoV-2 Omicron RBD with a conserved SARS-CoV RBD. In mice, this design generated cross-reactive neutralizing antibodies and protection against both Omicron and SARS-CoV, supporting antigen architecture as a strategy for broader coronavirus mRNA vaccine development.
-
(S)-(+)-Methoprene Workflows for JH Research
2026-08-29
(S)-(+)-Methoprene is a practical juvenile hormone analog for separating receptor-driven developmental effects from upstream hormone-biosynthesis regulation. This workflow-focused guide shows how to pair Met activation with miRNA, transcriptional, developmental, and comparative receptor assays while avoiding common dosing and stability errors.
-
Br-DAPI Workflows for DNA Imaging in Cardiac Models
2026-08-28
Br-DAPI combines membrane-permeable nuclear labeling with fluorescence amplification for flexible live-cell and fixed-cell analysis. This workflow applies it to palmitate-stressed cardiomyocytes, helping researchers normalize lipotoxicity assays while avoiding the common mistake of treating DNA signal as a direct apoptosis measurement.
-
miR-18a, ALOXE3, and Ferroptosis in GBM
2026-08-28
This study defines a mechanistic link between miR-18a, ALOXE3-dependent lipid metabolism, ferroptosis resistance, and glioblastoma migration. Its key contribution is to connect an upstream microRNA with both tumor-cell survival and 12-HETE-driven signaling, providing a framework for studying how lipid metabolic changes shape GBM progression.
-
CA-074 Me: Cathepsin B Inhibitor Workflows
2026-08-27
CA-074 Me enables cell-permeable inhibition of intracellular cathepsin B for dissecting lysosomal membrane permeabilization, necroptosis, and apoptosis-related phenotypes. This guide translates the MLKL–lysosome mechanism into practical imaging, inhibitor-control, and troubleshooting workflows while highlighting cathepsin L and solvent-related limitations.
-
Mitochondrial Permeability Transition Pore Assay Kit Guide
2026-08-27
Translate mitochondrial injury into a measurable fluorescence signal with a Calcein AM fluorescent probe workflow designed for pore-opening studies. This guide connects assay setup, disease-model applications, and troubleshooting to the multiparameter findings reported in idiopathic carpal tunnel syndrome research.
-
Prednisone as a Benchmark for Immune Assays
2026-08-26
Prednisone is a synthetic corticosteroid that enables mechanistically resolved studies of lymphocyte suppression and apoptosis. This article develops a benchmark strategy linking Prednisone-controlled immune assays with lessons from digestive LC–MS/MS metabolomics of botanical extracts.